The Uromigos and Dr. Jonathan Rosenberg, medical oncologist at Memorial Sloan Kettering Cancer Center, discuss everything you wanted to know about FGFR inhibition but were afraid to ask.
The Uromigos Episode 37: Regoratinib (FGFR inhibitor) and Atezolizumab in UC With Jonathan Rosenberg
By The Uromigos - Last Updated: September 21, 2022
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.